Whalesbook
The Transaction Details
Span Divergent Limited has completed a preferential allotment to Neev Nirav Jogani, who acquired 18,01,481 equity shares. This transaction brings Mr. Jogani's stake to 24.80% of the company's total voting capital, with a total consideration of ₹5.79 crore. The shares were issued at ₹32.16 per share. The deal was completed on March 28, 2026, and disclosed on April 1, 2026.
Significance of the Investment
The entry of Neev Nirav Jogani as a substantial shareholder is expected to provide Span Divergent with fresh capital and potentially new strategic direction. As a holding company with interests in food, agriculture, and life sciences, this infusion could support operational improvements or expansion plans.
Company Background and Approvals
Span Divergent, formerly known as Span Diagnostics Ltd., traces its roots back to 1972, having diversified from its initial diagnostic testing business. The board approved the preferential allotment on January 23, 2026, followed by shareholder approval at an Extraordinary General Meeting (EGM) on February 20, 2026. The Bombay Stock Exchange (BSE) granted its in-principle approval for the issue on March 19, 2026. The issue price of ₹32.16 per share was a premium to the face value and the market price at the time of approval. Notably, Nirav Dineshchandra Jogani, who may be related to Neev Nirav Jogani, previously served as an Independent Non-Executive Director on Span Divergent's board from 2024 to 2025, suggesting a prior connection to the company.
Impact on Ownership and Capital
The allotment alters Span Divergent's ownership structure, with Neev Nirav Jogani becoming a significant stakeholder. The company's paid-up share capital has increased from ₹5.46 crore to ₹7.26 crore as a result of this issuance. This strategic move may signal upcoming shifts in strategy or growth initiatives driven by the new investor.
Potential Risks and Challenges
Span Divergent has a history of weak sales growth and negative profitability. Recent quarterly results show revenue growth but a sharp decline in net profit and margins, indicating ongoing financial difficulties. Existing shareholders face equity dilution due to the issuance of new shares. The effective utilization of the ₹5.79 crore raised will be a key factor to monitor, alongside the new shareholder's strategic direction.
Industry Context
Span Divergent's diversified business model across food, agriculture, and life sciences makes direct peer comparison difficult. While companies like Patanjali Foods Ltd., EID Parry India Ltd., and Britannia Industries Ltd. operate in related sectors, Span Divergent's structure as a holding company and its financial performance distinguish it from its peers.
Recent Financial Performance
In the third quarter of fiscal year 2026 (Q3 FY26), Span Divergent's revenue rose by 78.39% year-on-year to ₹4.21 crore. However, net profit decreased sharply by -546.67% year-on-year to ₹0.97 crore during the same period.
Investor Outlook
Investors will be watching for announcements about how Neev Nirav Jogani plans to leverage his stake and influence. Future company filings will detail the deployment of the raised funds and any strategic changes across its business segments. Monitoring the company's financial results in upcoming quarters will be crucial to assess the impact of this capital infusion. The listing and trading approval for the newly allotted shares by the stock exchange is the next procedural step.